Metal based neurodegenerative diseases - From molecular mechanisms to therapeutic strategies

被引:230
|
作者
Crichton, Robert R. [1 ]
Dexter, D. T. [2 ]
Ward, Roberta J. [1 ,2 ,3 ]
机构
[1] Catholic Univ Louvain, Unite Biochim, B-1348 Louvain, Belgium
[2] Imperial Coll, Dept Cellular & Mol Neurosci, London W6 8RF, England
[3] Univ Florence, Dipartimento Farmacol Preclin, I-50121 Florence, Italy
关键词
neurodegeneration; iron; copper; zinc; Parkinson's disease; Alzheimer's disease; therapeutics;
D O I
10.1016/j.ccr.2007.10.019
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The hypothesis is presented that changes in metal ion homeostatic control, particularly of redox-active metals such as iron and copper, in specific brain regions, leads to the generation of reactive oxygen species, which either directly damage key proteins, or lead to the formation of reactive aldehydes. These, in turn, generate protein carbonyls, leading to protein denaturation, aggregation, and a failure of the ubiquitin/proteasome system to eliminate these defective proteins. We present the evidence for metal based neurodegeneration in Parkinson's and Alzheimer's disease. Possible therapeutic strategies are presented which could remove such excesses of these specific metals and lead to the diminishment of the neurodegenerative processes. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1189 / 1199
页数:11
相关论文
共 50 条
  • [1] Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
    Zhang, Xingyu
    Wang, Jiangyu
    Zhang, Zhentao
    Ye, Keqiang
    [J]. TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01):
  • [2] Metal-Based Therapeutic Strategies of Neurodegenerative Diseases
    Zhang Shibing
    Wang Ying
    Liu Changlin
    [J]. PROGRESS IN CHEMISTRY, 2009, 21 (05) : 903 - 910
  • [3] Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies
    Chen Xiang
    Xiao Yousheng
    Zhu Xiaolei
    Yang Wenjie
    Pu Jiali
    Pei Zhong
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [4] Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
    Bernardo, Antonietta
    Visentin, Sergio
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [5] Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative Diseases
    Li, Jin
    Yu, Hongni
    Yang, Chuan
    Ma, Tao
    Dai, Yuan
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
    Lijun Dai
    Li Zou
    Lanxia Meng
    Guifen Qiang
    Mingmin Yan
    Zhentao Zhang
    [J]. Molecular Neurobiology, 2021, 58 : 2183 - 2201
  • [7] Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
    Dai, Lijun
    Zou, Li
    Meng, Lanxia
    Qiang, Guifen
    Yan, Mingmin
    Zhang, Zhentao
    [J]. MOLECULAR NEUROBIOLOGY, 2021, 58 (05) : 2183 - 2201
  • [8] Molecular mechanisms and therapeutic strategies for prion diseases
    Katamine, S
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 8P - 8P
  • [9] Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
    Haddadi, Rasool
    Shahidi, Zahra
    Eyvari-Brooshghalan, Shahla
    [J]. PHYTOMEDICINE, 2020, 79
  • [10] Molecular mechanisms and therapeutic strategies for neuromuscular diseases
    Andrea, Zambon Alberto
    Matteo, Falzone Yuri
    Alessandra, Bolino
    Carlo, Previtali Stefano
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)